I rom Pharmaceutical - Ownership and Business Overview

Medical ProductsCompany

I rom Pharmaceutical Ownership

Who owns I rom Pharmaceutical?

I rom Pharmaceutical is owned by Kyowa Pharmaceutical Industry. It was acquired on November 30, 2011.

I rom Pharmaceutical Business Overview

Where is I rom Pharmaceutical headquartered?

I rom Pharmaceutical is headquartered in Tokyo, Japan.

What sector is I rom Pharmaceutical in?

I rom Pharmaceutical is a medical products company.

When was I rom Pharmaceutical founded?

I rom Pharmaceutical was founded in 1947.

Medical Products M&A Summary in 2011

Out of 60 sectors in the Mergr database, medical products ranked 7 in number of deals in 2011. The largest medical products acquisition in 2011 was Synthes - which was acquired by Johnson & Johnson for $19.3B.

Subscribe to Mergr to view all 190 acquisitions of medical products companies in 2011, including 40 acquisitions by private equity firms, and 150 by strategics.

I'rom Pharmaceutical Co.,Ltd.

6-14-1, Nishishinjuku Shinjuku-ku,
Tokyo, 160-0023
Japan,
81 3 5324 5320
www.irom-pharma.co.jp

I'rom Pharmaceutical Co.,Ltd. is a manufacturer of an injectibles and pharmaceutical products.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for I rom Pharmaceutical

Medical Products Companies